Daunorubicin citrate liposome Intravenous and Novoeight recombinant
Determining the interaction of Daunorubicin citrate liposome Intravenous and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daunorubicin liposomal
Brand name: DaunoXome
Synonyms: Daunorubicin (Liposomal), DAUNOrubicin (Liposomal)
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daunorubicin citrate liposome Intravenous-Novolin 70/30
- Daunorubicin citrate liposome Intravenous-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Daunorubicin citrate liposome Intravenous-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Daunorubicin citrate liposome Intravenous-Novolin N
- Daunorubicin citrate liposome Intravenous-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Daunorubicin citrate liposome Intravenous-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Daunorubicin hydrochloride
- Novoeight recombinant-Daunorubicin Intravenous
- Novoeight recombinant-DaunoXome
- Novoeight recombinant-Daurismo
- Novoeight recombinant-Daxbia
- Novoeight recombinant-Dayhist Allergy 12 Hour Relief